1. Chen, Xueyi, Liu, Ping, Zhang, Wei, Xiong, Yuyan, Qian, Lu. 2023. ETNPPL modulates hyperinsulinemia-induced insulin resistance through the SIK1/ROS-mediated inactivation of the PI3K/AKT signaling pathway in hepatocytes. In Journal of cellular physiology, 238, 1046-1062. doi:10.1002/jcp.30993. https://pubmed.ncbi.nlm.nih.gov/36924049/
2. White, Cory J, Ellis, Jessica M, Wolfgang, Michael J. 2021. The role of ethanolamine phosphate phospholyase in regulation of astrocyte lipid homeostasis. In The Journal of biological chemistry, 297, 100830. doi:10.1016/j.jbc.2021.100830. https://pubmed.ncbi.nlm.nih.gov/34048714/
3. Xu, Man, Guo, Ying-Ying, Li, Dan, Huang, Si-Hui, Tang, Qi-Zhu. 2022. Screening of Lipid Metabolism-Related Gene Diagnostic Signature for Patients With Dilated Cardiomyopathy. In Frontiers in cardiovascular medicine, 9, 853468. doi:10.3389/fcvm.2022.853468. https://pubmed.ncbi.nlm.nih.gov/35433888/
4. Zhang, Yun, Shen, Li, Wang, Bojun, Wu, Xiaohong. 2023. Ethanolamine-phosphate phospho-lyase (ETNPPL) contributes to the diagnosis, prognosis, and therapy of hepatocellular carcinoma. In PeerJ, 11, e15834. doi:10.7717/peerj.15834. https://pubmed.ncbi.nlm.nih.gov/37637156/
5. Leventoux, N, Augustus, M, Azar, S, Rigau, V, Hugnot, J P. 2020. Transformation Foci in IDH1-mutated Gliomas Show STAT3 Phosphorylation and Downregulate the Metabolic Enzyme ETNPPL, a Negative Regulator of Glioma Growth. In Scientific reports, 10, 5504. doi:10.1038/s41598-020-62145-1. https://pubmed.ncbi.nlm.nih.gov/32218467/
智鼠故事 
